{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:20:15Z","timestamp":1775006415547,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21nf0101636h0001"],"award-info":[{"award-number":["21nf0101636h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.cmi.2023.04.006","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T11:30:55Z","timestamp":1681126255000},"page":"904-910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of the 23-valent pneumococcal polysaccharide vaccine on the incidence of hospitalization with pneumonia in adults aged \u226565\u00a0years: retrospective cohort study using a population-based database in Japan"],"prefix":"10.1016","volume":"29","author":[{"given":"Hayato","family":"Yamana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Michihata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisuke","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2023.04.006_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","article-title":"Clinical and economic burden of community-acquired pneumonia among adults in Europe","volume":"67","author":"Welte","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2023.04.006_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.04.006_bib3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10096-019-03485-3","article-title":"Adult vaccination for pneumococcal disease: a comparison of the national guidelines in Europe","volume":"38","author":"Bonnave","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2023.04.006_bib4","first-page":"CD000422","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"2013","author":"Moberley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2023.04.006_bib5","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.vaccine.2016.02.024","article-title":"The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: a systematic review and meta-analysis","volume":"34","author":"Kraicer-Melamed","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2023.04.006_bib6","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1016\/j.vaccine.2016.06.045","article-title":"Corrigendum to The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: a systematic review and meta-analysis [Vaccine 34 (2016) 1540\u20131550]","volume":"34","author":"Kraicer-Melamed","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2023.04.006_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169368","article-title":"Effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPV23) against pneumococcal disease in the elderly: systematic review and meta-analysis","volume":"12","author":"Falkenhorst","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2023.04.006_bib8","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.vaccine.2016.02.023","article-title":"Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: a systematic review and meta-analysis of randomized trials","volume":"34","author":"Diao","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2023.04.006_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146338","article-title":"Efficacy of PPV23 in preventing pneumococcal pneumonia in adults at increased risk \u2013 a systematic review and meta-analysis","volume":"11","author":"Schiffner-Rohe","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2023.04.006_bib10","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJMoa022678","article-title":"Effectiveness of pneumococcal polysaccharide vaccine in older adults","volume":"348","author":"Jackson","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.04.006_bib11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1086\/507340","article-title":"Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 Study","volume":"43","author":"Vila-C\u00f3rcoles","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.04.006_bib12","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1016\/j.vaccine.2015.04.068","article-title":"The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old-Taiwan\u2019s PPV vaccination program","volume":"33","author":"Tsai","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2023.04.006_bib13","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/cid\/ciu002","article-title":"Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged \u2265 60 years: 3 years of follow-up in the CAPAMIS study","volume":"58","author":"Ochoa-Gondar","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.04.006_bib14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.cmi.2017.08.010","article-title":"Impact of pneumococcal polysaccharide vaccine on incidence and mortality after pneumonia in adults aged \u226560 years\u2014a population-based retrospective cohort study","volume":"24","author":"Kolditz","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.04.006_bib15","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.vaccine.2014.02.048","volume":"32","author":"Wiemken","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2023.04.006_bib16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1473-3099(17)30049-X","article-title":"Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study","volume":"17","author":"Suzuki","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.04.006_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171943","article-title":"Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain","volume":"12","author":"Dom\u00ednguez","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2023.04.006_bib18","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1016\/j.vaccine.2019.04.017","article-title":"Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: a case-control study","volume":"37","author":"Kim","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2023.04.006_bib19","article-title":"Pneumococcal infections in 2017, Japan","volume":"39","year":"2018","journal-title":"Infect Agents Surveill Rep"},{"key":"10.1016\/j.cmi.2023.04.006_bib20","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1016\/j.vaccine.2018.08.023","article-title":"The impact on vaccination coverage following introduction of a routine pneumococcal vaccination programme for the elderly in Japan","volume":"36","author":"Shono","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2023.04.006_bib21","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(11)60828-3","article-title":"Japanese universal health coverage: evolution, achievements, and challenges","volume":"378","author":"Ikegami","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2023.04.006_bib22","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.cmi.2023.04.006_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jama.2012.96867","article-title":"Prespecified falsification end points: can they validate true observational associations?","volume":"309","author":"Prasad","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2023.04.006_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122247","article-title":"The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study","volume":"10","author":"Morimoto","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2023.04.006_bib25","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2012.09.019","article-title":"Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales","volume":"30","author":"Andrews","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2023.04.006_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eclinm.2018.12.007","article-title":"Effectiveness of 23-valent polysaccharide pneumococcal vaccine and changes in invasive pneumococcal disease incidence from 2000 to 2017 in those aged 65 and over in England and Wales","volume":"6","author":"Djennad","year":"2018","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cmi.2023.04.006_bib27","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3201\/eid2111.142029","article-title":"Serotype changes and drug resistance in invasive pneumococcal diseases in adults after vaccinations in children, Japan, 2010-2013","volume":"21","author":"Ubukata","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2023.04.006_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jiac.2015.07.002","article-title":"Distribution and annual changes in Streptococcus pneumoniae serotypes in adult Japanese patients with pneumonia","volume":"21","author":"Akata","year":"2015","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.cmi.2023.04.006_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12879-016-2113-y","article-title":"Invasive pneumococcal disease among adults in Japan, April 2013 to March 2015: disease characteristics and serotype distribution","volume":"17","author":"Fukusumi","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2023.04.006_bib30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jiac.2017.01.008","article-title":"The distribution and annual changes in the Streptococcus pneumoniae serotypes in adult Japanese patients with pneumococcal pneumonia from 2011 to 2015","volume":"23","author":"Akata","year":"2017","journal-title":"J\u00a0Infect Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23001611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23001611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:34:10Z","timestamp":1761118450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X23001611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1198743X23001611"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2023.04.006","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of the 23-valent pneumococcal polysaccharide vaccine on the incidence of hospitalization with pneumonia in adults aged \u226565\u00a0years: retrospective cohort study using a population-based database in Japan","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2023.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}